Strides Shasun plans to list biotech business, while Aurobindo Pharma looks to acquire Portuguese drug maker Generis Farmaceutica. Also, Burman GSC has bought out Ascendas India’s 51 per cent stake in Gurgaon property.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
